Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Pediatric Endocrinology

When to Start Growth Hormone for Turner Syndrome

At a Glance

There is no specific age to start growth hormone therapy for Turner syndrome. Doctors recommend starting as soon as a child's growth drops significantly below the normal curve, which often happens between 2 and 4 years old. Early treatment helps maximize final adult height.

The current clinical consensus recommends starting recombinant human growth hormone (rhGH) therapy as soon as a child’s growth drops significantly below the normal curve, rather than waiting for a specific age [1]. For many girls with Turner syndrome, this growth failure becomes apparent between 2 and 4 years old, though treatment can sometimes begin as early as 12 to 18 months [2]. Initiating treatment early maximizes your daughter’s final adult height and allows for a longer period of steady, gradual growth [3][4].

It is completely normal to feel anxious or overwhelmed at the prospect of giving your young child daily injections. Fortunately, modern treatments are designed to be as patient-friendly as possible, and your care team will support you every step of the way.

Understanding the Growth Curve in Turner Syndrome

Short stature is one of the most common and universal features of Turner syndrome [5]. While girls with Turner syndrome are often born only slightly smaller than average, their growth velocity (the speed at which they grow) typically begins to slow down significantly after birth [2].

By the time a girl with Turner syndrome is approximately 2 years old, her growth rate usually declines further [2]. If left untreated, she will not experience the typical growth spurt during puberty, resulting in a final adult height that is significantly shorter than her genetic potential [2]. Because this growth deceleration happens gradually, regular measurements by a pediatrician are essential to catch the moment her height drops below the normal range—often defined as falling below the 3rd percentile on a standard growth chart [6][7].

Current Clinical Guidelines

The management of Turner syndrome is guided by international consensus guidelines, updated in 2024 and endorsed by major medical organizations [1]. These guidelines emphasize that there is no universal “right age” to start; instead, the right time is when growth failure is first identified [1].

Key recommendations include:

  • Early Initiation: Starting therapy early yields better growth outcomes than waiting [1][2].
  • The Risk of Delay: Delaying the start of growth hormone therapy until after age 7 or 8 is associated with reduced gains in final adult height, as the child has less time to catch up before their bones stop growing [4][8].
  • Individualized Care: The decision to start therapy, as well as the dosing strategy, must be customized to your daughter’s specific needs, weight, and response to the medication [1][9].

What to Expect with Daily Injections

The thought of daily injections can be terrifying for parents. However, rhGH is given as a very small, subcutaneous (under the skin) injection [10]. Today, this is typically done using an auto-injector pen device that hides the tiny needle, making the process quick and relatively painless [10].

Adherence is critical; skipping doses can significantly limit how well the treatment works, so some modern pen devices even track doses electronically to help families stay on schedule [11][10].

Safety, Side Effects, and Monitoring

Growth hormone therapy is generally safe and well-tolerated, but it requires careful medical supervision [1][12]. Your pediatric endocrinologist will see your daughter regularly (often every 3 to 6 months) to track her progress and check for potential side effects [13].

Important safety considerations include:

  • Bone and Joint Issues: Because growth hormone causes bones to grow quickly, it can occasionally lead to joint pain or unmask spinal issues like scoliosis [14][15]. Always tell your doctor if your daughter develops a limp, knee pain, or hip pain [16][17].
  • Routine Lab Work: Your doctor will order regular blood tests to ensure the dose is safe and effective [13].
  • Severe Headaches: Though rare, some children may experience increased pressure in the brain. You should report any severe headaches, nausea, or vision changes immediately [18].

Looking Ahead: Other Treatments

The primary goal of starting early is to allow your daughter to grow at a normal rate alongside her peers during childhood [19][20]. Later in childhood, your doctor may discuss adding other medications to further support growth. For example, they may recommend oxandrolone, a very mild anabolic steroid, which can provide an extra boost to final adult height [9][21].

Eventually, your daughter will also need estrogen therapy to induce puberty [19]. Because estrogen causes the growth plates in the bones to fuse (which permanently stops height growth), your endocrinologist will carefully time the introduction of estrogen so she can experience puberty at an appropriate age without compromising her final adult height [19].

Common questions in this guide

At what age should a child with Turner syndrome start growth hormone?
There is no single correct age to begin treatment. Specialists recommend starting as soon as a child's growth drops significantly below the normal growth curve, which typically happens between 12 months and 4 years of age.
Why is it important to start growth hormone early for Turner syndrome?
Starting treatment early provides a longer period of steady growth before the bones stop growing. Delaying therapy until a child is older can reduce the total height they are able to gain from the medication.
How is growth hormone administered?
The medication is given as a very small daily injection just under the skin. Most families use a modern auto-injector pen device that hides the tiny needle, making the process quick and relatively painless for the child.
What are the side effects of growth hormone therapy for Turner syndrome?
Therapy is generally safe but requires careful monitoring. Because the medication causes bones to grow quickly, it can sometimes lead to joint pain or reveal spinal issues like scoliosis. Rarely, children may experience severe headaches that require immediate medical attention.
How does growth hormone affect puberty in Turner syndrome?
Growth hormone does not trigger puberty, so your daughter will likely need estrogen therapy when she is older. Your doctor will carefully time when to start estrogen so she can experience puberty alongside her peers without permanently stopping her bone growth too early.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific height milestones or percentiles are you watching for to decide when it's time to start growth hormone for my daughter?
  2. 2.Can you show me the different types of injection pens or delivery devices available, and which one you recommend for a child her age?
  3. 3.What is the schedule for monitoring her progress, bloodwork, and potential side effects once she starts therapy?
  4. 4.How do we navigate insurance approvals for growth hormone therapy, and does the clinic offer support or a dedicated coordinator for this process?
  5. 5.If she starts treatment now, how will you balance the timing of estrogen therapy later on so that she can start puberty without compromising her final height?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Growth and Growth-Promoting Treatments in Turner Syndrome.

    Kanakatti Shankar R, Quigley CA, Isojima T, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2025; (199(1)):e32133 doi:10.1002/ajmg.c.32133.

    PMID: 39950365
  2. 2

    Growth in girls with Turner syndrome.

    Isojima T, Yokoya S

    Frontiers in endocrinology 2022; (13()):1068128 doi:10.3389/fendo.2022.1068128.

    PMID: 36714599
  3. 3

    Final Adult Height after Growth Hormone Treatment in Patients with Turner Syndrome.

    Ahn JM, Suh JH, Kwon AR, et al.

    Hormone research in paediatrics 2019; (91(6)):373-379 doi:10.1159/000500780.

    PMID: 31480041
  4. 4

    Response to Recombinant Human Growth Hormone (rhGH) Therapy in Children with Growth Hormone Deficiency.

    Riaz M, Ibrahim MN, Rai VR, et al.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2024; (34(8)):932-935 doi:10.29271/jcpsp.2024.08.932.

    PMID: 39113512
  5. 5

    Clinical Features of Girls with Turner Syndrome in a Single Centre in Malaysia.

    Lee YL, Wu LL

    Journal of the ASEAN Federation of Endocrine Societies 2019; (34(1)):22-28 doi:10.15605/jafes.034.01.05.

    PMID: 33442133
  6. 6

    Multiple Pituitary Hormone Deficiency, Empty Sella and Ectopic Neurohypophysis in Turner Syndrome.

    Dutta D, Selvan C, Mukhopadhyay S

    Indian pediatrics 2015; (52(9)):803-4 doi:10.1007/s13312-015-0721-z.

    PMID: 26519720
  7. 7

    Still too little, too late? Ten years of growth hormone therapy baseline data from the NordiNet® International Outcome Study.

    Polak M, Konrad D, Tønnes Pedersen B, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2018; (31(5)):521-532 doi:10.1515/jpem-2017-0489.

    PMID: 29652668
  8. 8

    Factors influencing growth in children with growth hormone deficiency - a case-control study.

    Lohiya N, Krishna Prasad H, Narayanasamy K, et al.

    Pediatric endocrinology, diabetes, and metabolism 2021; (27(1)):19-25 doi:10.5114/pedm.2020.101807.

    PMID: 33599432
  9. 9

    Growth During Pubertal Induction in Girls With Turner Syndrome: A Retrospective Cohort Analysis.

    Nicholls J, Harris M, Hughes I, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(11)):e1992-e2000 doi:10.1210/clinem/dgae071.

    PMID: 38332670
  10. 10

    Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.

    Su PH, Yang C, Chao MC, Chiang CL

    JMIR pediatrics and parenting 2021; (4(1)):e14774 doi:10.2196/14774.

    PMID: 33448936
  11. 11

    Effect of adherence to growth hormone treatment on 0-2 year catch-up growth in children with growth hormone deficiency.

    van Dommelen P, Koledova E, Wit JM

    PloS one 2018; (13(10)):e0206009 doi:10.1371/journal.pone.0206009.

    PMID: 30356273
  12. 12

    Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.

    Backeljauw P, Kanumakala S, Loche S, et al.

    Hormone research in paediatrics 2021; (94(3-4)):133-143 doi:10.1159/000515875.

    PMID: 34350858
  13. 13

    Evolving growth hormone deficiency: proof of concept.

    Chimatapu SN, Sethuram S, Samuels JG, et al.

    Frontiers in endocrinology 2024; (15()):1398171 doi:10.3389/fendo.2024.1398171.

    PMID: 38752175
  14. 14

    Influence of growth hormone treatment on radiographic indices of the spine: propensity-matched analysis.

    Yun YH, Kwon SS, Koh Y, et al.

    Journal of orthopaedic surgery and research 2017; (12(1)):130 doi:10.1186/s13018-017-0630-z.

    PMID: 28877703
  15. 15

    Idiopathic short stature and scoliosis in children treated with growth hormone.

    Hong H, Pan X, Song J, et al.

    The bone & joint journal 2023; (105-B(4)):439-448 doi:10.1302/0301-620X.105B4.BJJ-2022-0898.R1.

    PMID: 36924176
  16. 16

    Strong Association Between Growth Hormone Therapy and Proximal Tibial Physeal Avulsion Fractures in Children and Adolescents: A Case-Control Study.

    Beber SA, Gross PW, Nichols E, et al.

    The Journal of bone and joint surgery. American volume 2024; (106(3)):227-231 doi:10.2106/JBJS.23.00741.

    PMID: 38127811
  17. 17

    Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.

    Schott DA, Stumpel CTRM, Klaassens M

    American journal of medical genetics. Part A 2019; (179(2)):219-223 doi:10.1002/ajmg.a.60696.

    PMID: 30556359
  18. 18

    Autoimmune polyglandular syndrome type 2 manifested as Hashimoto's thyroiditis and adrenocortical insufficiency, in Turner syndrome woman, with onset following introduction of treatment with recombinant human growth hormone.

    Cyniak-Magierska A, Lasoń A, Smyczyńska J, Lewiński A

    Neuro endocrinology letters 2015; (36(2)):119-23.

    PMID: 26071578
  19. 19

    Evolution of Health Care in Turner Syndrome.

    Kanakatti Shankar R, Gravholt CH, Backeljauw PF

    American journal of medical genetics. Part C, Seminars in medical genetics 2025; (199(1)):e32124 doi:10.1002/ajmg.c.32124.

    PMID: 39610314
  20. 20

    Growth Hormone Therapy for Turner Syndrome.

    Blunden C, Nasomyont N, Backeljauw P

    Pediatric endocrinology reviews : PER 2018; (16(Suppl 1)):80-90 doi:10.17458/per.vol16.2018.bnb.ghtherapyturnersyndrome.

    PMID: 30378785
  21. 21

    Effect of oxandrolone therapy on adult height in Turner syndrome patients treated with growth hormone: a meta-analysis.

    Sheanon NM, Backeljauw PF

    International journal of pediatric endocrinology 2015; (2015(1)):18 doi:10.1186/s13633-015-0013-3.

    PMID: 26322078

This page provides educational information about growth hormone therapy for Turner syndrome. Always consult your pediatric endocrinologist for specific medical advice and personalized treatment decisions for your child.

Get notified when new evidence is published on Turner syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.